Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

By Zoe Arvanitakis, R. Wilson, Julia L. Bienias, Denis A. Evans, David A. Bennett. Archives of Neurology, 2004

1,267 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/c887f831f9e4b266b4a5f66722dc5d549baccc14

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. S. Peters
2. R. Huxley
3. M. Woodward
4. Bruce S. McEwen
5. C. Zhong
6. Zhichun Chen
7. Christine Marcelle Heim
8. Elisabeth B. Binder

In Physiology

1. Yaakov Stern
2. Reisa A. Sperling
3. Clifford R. Jack Jr.
4. William H. Thies
5. P. Aisen
6. M. Carillo
7. Thomas J. Montine
8. Ruth Peters

In Psychiatry and Mental health

1. Yaakov Stern
2. William H. Thies
3. Reisa A. Sperling
4. David S. Knopman
5. Clifford R. Jack Jr.
6. P. Aisen
7. Thomas J. Montine
8. Ruth Peters

Citations in the corpus

• Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005, neutral): “Eight studies reported a variety of other cognitive tests, most of them reporting greater or equal cognitive change for the diabetic participants (Table 1) [46, 49, 51, 58, 63, 66, 69, 70].”
• Introduction to Revised Criteria for the Diagnosis of Alzheimer’s Disease: National Institute on Aging and the Alzheimer Association Workgroups (2011, background): “In particular, vascular risk factors such as hypertension, hypercholesterolemia, and diabetes have been associated with an increased risk of dementia, and may contribute directly to the effect of AD pathology on the aging brain [13,14].”
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011, positive): “In particular, vascular risk factors such as hypertension, hypercholesterolemia, and diabetes have been associated with an increased risk of dementia, and may contribute directly to the effect of AD pathology on the aging brain [13,14].”
• Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. (2005, background): “The relationship between diabetes, cognitive decline, and Alzheimer’s disease is still under active investigation, but some studies suggest that diabetes may be associated with an increased risk of developing Alzheimer’s disease, along with enhanced decline in some cognitive systems (Arvanitakis et ”
• Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia (2015, background): “Two prospective neuropathological cohort studies (28,29) suggested that diabetes may”
• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. (2013, background): “The individuals with T2DM have a two-to three-fold increased relative risk of AD, independent of the risk for vascular dementia (Arvanitakis et al., 2004; Leibson et al., 1997).”
• Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. (2006, background): “With diabetes there is also poorer cognitive function, as well as increased depression (see reference [41] and other articles in this volume) and increased risk for Alzheimer’s disease [42,43].”